[시장보고서]환자 모니터링 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

환자 모니터링 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Patient Monitoring Devices Market Size, Share & Trends Analysis Report By Product, By End-use, By Region, And Segment Forecasts, 2026 - 2033

상품코드 : 1908258

리서치사 : Grand View Research

발행일 : 2025년 12월

페이지 정보 : 영문 120 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,698,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,160,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 13,084,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

환자 모니터링 기기 시장 개요

세계의 환자 모니터링 기기 시장 규모는 2025년에 543억 3,000만 달러로 추정되며, 2033년에 1,182억 1,000만 달러에 달할 것으로 예측됩니다.

2026-2033년에는 CAGR 10.5%로 성장할 것으로 예상됩니다. 이 산업의 확대는 혈압, 체온, 혈중 산소포화도 등 다양한 생체 데이터를 측정, 기록, 표시하는 모니터링 장비에 대한 수요 증가에 기인합니다.

고령화 인구 증가, 심혈관질환, 당뇨병, 호흡기질환 등 만성질환의 유병률 증가, 지속적인 모니터링의 필요성 증가 등이 시장 성장을 이끄는 주요 촉진요인입니다. 예를 들어, 세계보건기구(WHO)의 추정에 따르면, 2030년까지 세계 인구 6명 중 1명이 60세 이상이 될 것으로 예상되며, 적시에 개입하고 원격의료를 가능하게 하는 기술에 대한 수요가 확대될 것입니다. 의료비 부담 증가와 인력 부족을 배경으로 원격의료와 원격 환자 모니터링 프로그램 도입이 진행되고 있습니다. 예를 들어, AMA 디지털 헬스케어 2022 조사에 따르면, 의사의 93%가 디지털 도구를 유용하다고 인식하고 있으며, 원격 환자 모니터링(RPM) 이용률은 2016년 이후 두 배 이상 증가한 30%에 달합니다. 이러한 보급 확대는 만성질환 관리, 급성기 이후 회복기 치료, 예방의학에서 커넥티드 모니터링 기기에 대한 임상의들의 강한 신뢰를 반영합니다.

소형화, 배터리 수명, 무선 연결성의 기술 개발이 시장을 더욱 견인하고 있습니다. 예를 들어, 미국 식품의약국(FDA)은 당뇨병 성인 환자를 위한 Dexcom의 G7 15일 연속 혈당 모니터링(CGM) 시스템을 승인했습니다. 이 차세대 기기는 최대 15.5일의 착용 기간, 8.0%의 평균 상대오차(MARD)로 정확도 향상, 12시간의 유예기간을 제공하여 현재 미국 시장에서 판매되는 CGM 중 가장 긴 지속시간과 가장 높은 정확도를 제공합니다. 마찬가지로, 2022년 9월 메드트로닉은 블루투스 연결 기능을 갖춘 이식형 심장 모니터 'LINQ II'의 FDA 승인을 발표했습니다. 본 제품은 의사에게 실시간 부정맥 데이터 전송을 가능하게 하여 조기 개입을 돕습니다. 이러한 혁신은 기기 설계와 연결성의 지속적인 개선이 원격 모니터링 기능을 강화하여 예방적 만성질환 관리를 지원하고 있음을 보여줍니다.

이러한 긍정적인 전망에도 불구하고, 데이터 보안에 대한 우려와 특정 원격 모니터링 서비스에 대한 상환 격차 등의 과제는 여전히 남아있습니다. 그러나 지속적인 기술 혁신, 임상의의 수용성 확대, 예방적 의료 관리에 중점을 둔 금액 기반 케어 모델로 인해 환자 모니터링 기기 시장은 예측 기간 동안 견조한 성장세를 보일 것으로 예상됩니다.

시장 계보 전망
- 상부 시장 전망
- 관련/부수 시장 전망
침투율과 성장 전망 매핑
제품 파이프라인 분석(단계별)
시장 역학
환자 모니터링 기기 : 시장 분석 툴
- 산업 분석 : Porter's Five Forces
- PESTEL 분석
주요 거래·전략적 제휴 분석
사용 사례 연구
기술적 진보

제4장 환자 모니터링 기기 시장 세분화, 제품별, 2021-2033년

제품별 시장 점유율 분석, 2025년과 2033년
세계의 환자 모니터링 기기 시장 : 제품별, 2021-2033년
시장 규모 및 예측과 동향 분석, 2021-2033년

제5장 환자 모니터링 기기 시장 세분화, 용도별, 2021-2033년

정의와 범위
최종 용도별 시장 점유율 분석, 2025년과 2033년
세계의 환자 모니터링 기기 시장 : 최종 용도별, 2021-2033년
병원
외래 수술 센터
재택의료 환경
기타

제6장 환자 모니터링 기기 시장 세분화, 지역별, 2021-2033년, 100만 달러

지역별 시장 점유율 분석, 2025년과 2033년
지역별 시장 대시보드
지역별 시장 개요
환자 모니터링 기기 지역별 시장 점유율, 2025년과 2033년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카

제7장 경쟁 구도

주요 시장 진입 기업의 최근 동향과 영향 분석
기업 분류
기업 점유율 분석(2025년,%)
기업 개요
- Bosch
- BIoTronik
- Welch Allyn
- Koninklijke Philips N.V.
- GE Healthcare
- Medtronic
- MASIMO CORPORATION
- Smith's Medical
- OMRON Corporation
- Mindray Medical India Pvt. Ltd.
- F. Hoffmann-La Roche Ltd
- Dragerwerk AG & Co. KGaA
- NIHON KOHDEN CORPORATION
- Natus Medical

KSM

영문 목차

영문목차

Patient Monitoring Devices Market Summary

The global patient monitoring devices market size was estimated at USD 54.33 billion in 2025 and is expected to reach USD 118.21 billion by 2033, growing at a CAGR of 10.5% from 2026 to 2033. The expansion of industry can be attributed to the increasing demand for monitoring devices that measure, record, and display various biometric data, including blood pressure, temperature, and blood oxygen saturation levels.

The growing geriatric population, rising prevalence of chronic conditions such as cardiovascular diseases, diabetes, and respiratory disorders, and the increasing need for continuous monitoring are key drivers supporting market growth. For instance, the World Health Organization estimates that by 2030, one in six people globally will be 60 years or older, amplifying the demand for technologies that enable timely intervention and remote care. Rising adoption of telehealth and remote patient monitoring programs driven by healthcare cost pressures and staffing shortages. For instance, the AMA Digital Health Care 2022 study highlighted that 93% of physicians find digital tools beneficial, with remote patient monitoring (RPM) usage more than doubling to 30% since 2016. This growing adoption reflects strong clinician confidence in connected monitoring devices for managing chronic diseases, post-acute recovery, and preventive care.

Technological developments in miniaturization, battery life, and wireless connectivity are further driving the market. For instance, in The FDA has cleared Dexcom's G7 15-Day Continuous Glucose Monitoring (CGM) system for adults with diabetes. This next-generation device offers up to 15.5 days of wear time, improved accuracy with an 8.0% MARD, and a 12-hour grace period, making it the longest-lasting and most precise CGM currently available in the U.S. market. Similarly, in September 2022, Medtronic announced the FDA clearance of its LINQ II insertable cardiac monitor with Bluetooth connectivity, offering real-time arrhythmia data transmission to physicians and facilitating earlier intervention. These innovations highlight how continuous improvements in device design and connectivity are enhancing remote monitoring capabilities and supporting proactive chronic disease management.

Despite the positive outlook, challenges remain, such as data security concerns and reimbursement gaps for certain remote monitoring services. However, with continuous innovation, growing acceptance by clinicians, and value-based care models emphasizing preventive health management, the patient monitoring devices market is poised to witness robust growth over the forecast period.

Global Patient Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global patient monitoring devices market report based on product, end-use, and regions.

Product Outlook (Revenue, USD Million, 2021 - 2033)
Blood Glucose Monitoring Systems
- Self-monitoring Blood Glucose Systems
- Continuous Glucose Monitoring Systems
Cardiac Monitoring Devices
- ECG Devices
- Implantable Loop Recorders
- Event Monitors
- Mobile Cardiac Telemetry Monitors
- Smart/Wearable ECG Monitors
Multi-parameter Monitoring Devices.
- Low-acuity Monitoring Devices
- Mid-acuity Monitoring Devices
- High-acuity Monitoring Devices
Respiratory Monitoring Devices
- Pulse Oximeters
- Spirometers
- Capnographs
- Peak Flow Meters
Temperature Monitoring Devices
- Handheld Temperature Monitoring Devices
- Table-top Temperature Monitoring Devices
- Wearable Continuous Monitoring Devices
- Invasive Temperature Monitoring Devices
- Smart Temperature Monitoring Devices
Hemodynamic/Pressure Monitoring Devices
- Hemodynamic Monitors
- Blood Pressure Monitors
- Disposables
Fetal & Neonatal Monitoring Devices
- Fetal Monitoring Devices
- Neonatal Monitoring Devices
Neuromonitoring Devices
- Electroencephalograph Machines
- Electromyography Machines
- Cerebral Oximeters
- Intracranial Pressure Monitors
- Magnetoencephalograph Machines
- Transcranial Doppler Machines
Weight Monitoring Devices
- Digital
- Analog
Wearable Drug Delivery Systems
Other Patient Monitoring Devices
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals
Ambulatory Surgery Centers
Home Care Settings
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
  - 1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. End use outlook
- 2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Patient Monitoring Devices Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.2. Market restraint analysis
- 3.4.3. Industry challenges Analysis
- 3.4.4. Industry Opportunity Analysis
3.5. Patient Monitoring Devices: Market Analysis Tools
- 3.5.1. Industry analysis - Porter's
  - 3.5.1.1. Supplier power
  - 3.5.1.2. Buyer power
  - 3.5.1.3. Substitution threat
  - 3.5.1.4. Threat from new entrant
  - 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL analysis
  - 3.5.2.1. Political landscape
  - 3.5.2.2. Environmental landscape
  - 3.5.2.3. Social landscape
  - 3.5.2.4. Technology landscape
  - 3.5.2.5. Legal landscape
3.6. Major deals & strategic alliances analysis
3.7. Case Studies
3.8. Technological Advancement

Chapter 4. Patient Monitoring Devices Market: Segment Analysis, by Product, 2021 - 2033 (USD Million)

4.1. Segment Dashboard
4.2. Product type Market Share Analysis, 2021 & 2033
4.3. Global Patient Monitoring Devices Market, by Product, 2021 to 2033
4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033
- 4.4.1. Blood Glucose Monitoring Systems
  - 4.4.1.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.1.2. Self-monitoring blood glucose systems
    - 4.4.1.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.1.3. Continuous Glucose Monitoring System
    - 4.4.1.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Cardiac Monitoring Devices
  - 4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.2.2. ECG Devices
    - 4.4.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.2.3. Implantable Loop Records
    - 4.4.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.2.4. Event Monitors
    - 4.4.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.2.5. Mobile Cardiac Telemetry Monitors
    - 4.4.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.2.6. Smart/Wearable ECG Monitors
    - 4.4.2.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Multi-parameter Monitoring Devices.
  - 4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.3.2. Low-acuity Monitoring Devices
    - 4.4.3.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.3.3. Mid-acuity Monitoring Devices
    - 4.4.3.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.3.4. High-acuity Monitoring Devices
    - 4.4.3.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Respiratory Monitoring Devices
  - 4.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.4.2. Pulse Oximeters
    - 4.4.4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.4.3. Spirometer
    - 4.4.4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.4.4. Capnographs
    - 4.4.4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.4.5. Peak Flow Meters
    - 4.4.4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.5. Temperature Monitoring Devices
  - 4.4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.5.2. Handheld Temperature Monitoring Devices
    - 4.4.5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.5.3. Table-top Temperature Monitoring Devices
    - 4.4.5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.5.4. Wearable Continuous Monitoring Devices
    - 4.4.5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.5.5. Invasive Temperature Monitoring Devices
    - 4.4.5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.6. Smart Temperature Monitoring Devices
  - 4.4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.7. Hemodynamic/ Pressure Monitoring Devices
  - 4.4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.7.2. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.7.3. Hemodynamic Monitoring Devices
    - 4.4.7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.7.4. Blood Pressure Monitors
    - 4.4.7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.7.5. Disposable
    - 4.4.7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.8. Fetal & Neonatal Monitoring Devices
  - 4.4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.8.2. Fetal Monitoring Devices
    - 4.4.8.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.8.3. Neonatal Monitoring Devices
    - 4.4.8.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.9. Neuromonitoring Devices
  - 4.4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.9.2. Electroencephalograph Machines
    - 4.4.9.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.9.3. Electromyography Machines
    - 4.4.9.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.9.4. Cerebral Oximeters
    - 4.4.9.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.9.5. Intracranial Pressure Monitors
    - 4.4.9.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.9.6. Magnetoencephalograph Machines
    - 4.4.9.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.9.7. Transcranial Doppler Machines
    - 4.4.9.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.10. Weight Monitoring Devices
  - 4.4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.10.2. Digital
    - 4.4.10.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  - 4.4.10.3. Analog
    - 4.4.10.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.11. Wearable Drug Delivery Systems
  - 4.4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.12. Other Patient Monitoring Devices
  - 4.4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Patient Monitoring Devices Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

5.1. Definition and Scope
5.2. End use Market Share Analysis, 2025 & 2033
5.3. Segment Dashboard
5.4. Global Patient Monitoring Devices Market, by End Use, 2021 to 2033
5.5. Hospitals
- 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Ambulatory Surgery Centers
- 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Home Care Settings
- 5.7.1. Home Care Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Others
- 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Patient Monitoring Devices Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

6.1. Regional Market Share Analysis, 2025 & 2033
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Patient Monitoring Devices Market Share by Region, 2025 & 2033:
6.5. North America
- 6.5.1. North America Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.5.2. U.S.
  - 6.5.2.1. Key Country Dynamics
  - 6.5.2.2. Regulatory Scenario
  - 6.5.2.3. Competitive Scenario
  - 6.5.2.4. U.S. Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.5.3. Canada
  - 6.5.3.1. Key Country Dynamics
  - 6.5.3.2. Regulatory Scenario
  - 6.5.3.3. Competitive Scenario
  - 6.5.3.4. Canada Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.5.4. Mexico
  - 6.5.4.1. Key Country Dynamics
  - 6.5.4.2. Regulatory Scenario
  - 6.5.4.3. Competitive Scenario
  - 6.5.4.4. Mexico Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
6.6. Europe
- 6.6.1. Europe Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.6.2. UK
  - 6.6.2.1. Key Country Dynamics
  - 6.6.2.2. Regulatory Scenario
  - 6.6.2.3. Competitive Scenario
  - 6.6.2.4. UK Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.6.3. Germany
  - 6.6.3.1. Key Country Dynamics
  - 6.6.3.2. Regulatory Scenario
  - 6.6.3.3. Competitive Scenario
  - 6.6.3.4. Germany Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.6.4. France
  - 6.6.4.1. Key Country Dynamics
  - 6.6.4.2. Regulatory Scenario
  - 6.6.4.3. Competitive Scenario
  - 6.6.4.4. France Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.6.5. Italy
  - 6.6.5.1. Key Country Dynamics
  - 6.6.5.2. Regulatory Scenario
  - 6.6.5.3. Competitive Scenario
  - 6.6.5.4. Italy Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.6.6. Spain
  - 6.6.6.1. Key Country Dynamics
  - 6.6.6.2. Regulatory Scenario
  - 6.6.6.3. Competitive Scenario
  - 6.6.6.4. Spain Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.6.7. Norway
  - 6.6.7.1. Key Country Dynamics
  - 6.6.7.2. Regulatory Scenario
  - 6.6.7.3. Competitive Scenario
  - 6.6.7.4. Norway Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.6.8. Sweden
  - 6.6.8.1. Key Country Dynamics
  - 6.6.8.2. Regulatory Scenario
  - 6.6.8.3. Competitive Scenario
  - 6.6.8.4. Sweden Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.6.9. Denmark
  - 6.6.9.1. Key Country Dynamics
  - 6.6.9.2. Regulatory Scenario
  - 6.6.9.3. Competitive Scenario
  - 6.6.9.4. Denmark Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
6.7. Asia Pacific
- 6.7.1. Japan
  - 6.7.1.1. Key Country Dynamics
  - 6.7.1.2. Regulatory Scenario
  - 6.7.1.3. Competitive Scenario
  - 6.7.1.4. Japan Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.7.2. China
  - 6.7.2.1. Key Country Dynamics
  - 6.7.2.2. Regulatory Scenario
  - 6.7.2.3. Competitive Scenario
  - 6.7.2.4. China Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.7.3. India
  - 6.7.3.1. Key Country Dynamics
  - 6.7.3.2. Regulatory Scenario
  - 6.7.3.3. Competitive Scenario
  - 6.7.3.4. India Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.7.4. Australia
  - 6.7.4.1. Key Country Dynamics
  - 6.7.4.2. Regulatory Scenario
  - 6.7.4.3. Competitive Scenario
  - 6.7.4.4. Australia Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.7.5. South Korea
  - 6.7.5.1. Key Country Dynamics
  - 6.7.5.2. Regulatory Scenario
  - 6.7.5.3. Competitive Scenario
  - 6.7.5.4. South Korea Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.7.6. Thailand
  - 6.7.6.1. Key Country Dynamics
  - 6.7.6.2. Regulatory Scenario
  - 6.7.6.3. Competitive Scenario
  - 6.7.6.4. Thailand Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
6.8. Latin America
- 6.8.1. Brazil
  - 6.8.1.1. Key Country Dynamics
  - 6.8.1.2. Regulatory Scenario
  - 6.8.1.3. Competitive Scenario
  - 6.8.1.4. Brazil Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.8.2. Argentina
  - 6.8.2.1. Key Country Dynamics
  - 6.8.2.2. Regulatory Scenario
  - 6.8.2.3. Competitive Scenario
  - 6.8.2.4. Argentina Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
6.9. MEA
- 6.9.1. South Africa
  - 6.9.1.1. Key Country Dynamics
  - 6.9.1.2. Regulatory Scenario
  - 6.9.1.3. Competitive Scenario
  - 6.9.1.4. South Africa Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.9.2. Saudi Arabia
  - 6.9.2.1. Key Country Dynamics
  - 6.9.2.2. Regulatory Scenario
  - 6.9.2.3. Competitive Scenario
  - 6.9.2.4. Saudi Arabia Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.9.3. UAE
  - 6.9.3.1. Key Country Dynamics
  - 6.9.3.2. Regulatory Scenario
  - 6.9.3.3. Competitive Scenario
  - 6.9.3.4. UAE Patient Monitoring Devices Market, 2021 - 2033 (USD Million)
- 6.9.4. Kuwait
  - 6.9.4.1. Key Country Dynamics
  - 6.9.4.2. Regulatory Scenario
  - 6.9.4.3. Competitive Scenario
  - 6.9.4.4. Kuwait Patient Monitoring Devices Market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Company Market Share Analysis, 2025 (%)
7.4. Company Profiles
- 7.4.1. Bosch
  - 7.4.1.1. Company overview
  - 7.4.1.2. Financial performance
  - 7.4.1.3. Product benchmarking
  - 7.4.1.4. Strategic initiatives
- 7.4.2. Biotronik
  - 7.4.2.1. Company overview
  - 7.4.2.2. Financial performance
  - 7.4.2.3. Product benchmarking
  - 7.4.2.4. Strategic initiatives
- 7.4.3. Welch Allyn
  - 7.4.3.1. Company overview
  - 7.4.3.2. Financial performance
  - 7.4.3.3. Product benchmarking
  - 7.4.3.4. Strategic initiatives
- 7.4.4. Koninklijke Philips N.V.
  - 7.4.4.1. Company overview
  - 7.4.4.2. Financial performance
  - 7.4.4.3. Product benchmarking
  - 7.4.4.4. Strategic initiatives
- 7.4.5. GE Healthcare
  - 7.4.5.1. Company overview
  - 7.4.5.2. Financial performance
  - 7.4.5.3. Product benchmarking
  - 7.4.5.4. Strategic initiatives
- 7.4.6. Medtronic
  - 7.4.6.1. Company overview
  - 7.4.6.2. Financial performance
  - 7.4.6.3. Product benchmarking
  - 7.4.6.4. Strategic initiatives
- 7.4.7. MASIMO CORPORATION
  - 7.4.7.1. Company overview
  - 7.4.7.2. Financial performance
  - 7.4.7.3. Product benchmarking
  - 7.4.7.4. Strategic initiatives
- 7.4.8. Smith's Medical
  - 7.4.8.1. Company overview
  - 7.4.8.2. Financial performance
  - 7.4.8.3. Product benchmarking
  - 7.4.8.4. Strategic initiatives
- 7.4.9. OMRON Corporation
  - 7.4.9.1. Company overview
  - 7.4.9.2. Financial performance
  - 7.4.9.3. Product benchmarking
  - 7.4.9.4. Strategic initiatives
- 7.4.10. Mindray Medical India Pvt. Ltd.
  - 7.4.10.1. Company overview
  - 7.4.10.2. Financial performance
  - 7.4.10.3. Product benchmarking
  - 7.4.10.4. Strategic initiatives
- 7.4.11. F. Hoffmann-La Roche Ltd
  - 7.4.11.1. Company overview
  - 7.4.11.2. Financial performance
  - 7.4.11.3. Product benchmarking
  - 7.4.11.4. Strategic initiatives
- 7.4.12. Dragerwerk AG & Co. KGaA
  - 7.4.12.1. Company overview
  - 7.4.12.2. Financial performance
  - 7.4.12.3. Product benchmarking
  - 7.4.12.4. Strategic initiatives
- 7.4.13. NIHON KOHDEN CORPORATION
  - 7.4.13.1. Company overview
  - 7.4.13.2. Financial performance
  - 7.4.13.3. Product benchmarking
  - 7.4.13.4. Strategic initiatives
- 7.4.14. Natus Medical
  - 7.4.14.1. Company overview
  - 7.4.14.2. Financial performance
  - 7.4.14.3. Product benchmarking
  - 7.4.14.4. Strategic initiatives